# AptaBio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aptabio-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Gyeonggi-do, South Korea
- Website: www.aptabio.com
- Total disclosed funding: $12M
- Latest round: Series B (Jun 22, 2016)
- Investors on record: 7

## About

Based in Gyeonggi-do, South Korea, and founded in 2009, AptaBio Therapeutics Inc. operates as a pharmaceutical bio company providing drugs that help in the treatment of vascular disorders, neurological diseases, diabetic complications, and intractable cancers using immunotherapy. In August 2023, AptaBio Therapeutics Inc. raised KRW 10.8 billion in PIPE funding from EN Investment, KB Investment, Shinhan Venture Investment, SL Investment, and T.S. Investment, with participation from Kolon Investment.

AptaBio Therapeutics Inc. provides support life science product development through Platform technology. The company developed a variety of drugs for medical and healthcare industry such as Lipofector-EXT, Lipofector-2000, Lipofector-NO, and Lipofector-pMAX, and many more. In addition, the company specializes in medical and pharmaceutical clinical research and their trials. AptaBio Therapeutics Inc. provides its research in disease such as diabetes, covid-19, Muscular degeneration, brain disease, and pancreatic cancer. 

The company plans to use the funding from August 2023 to support the operational costs of clinical trials and acquisition of shares in other companies.

## Funding rounds

- Series B, Jun 22, 2016, $8.1M — LB Investment, HB Investment, Posco Investment, ID Ventures, Kolon Investment, Wooshin Venture Capital
- Series A, Jun 13, 2015, $3.5M — Shinhan Capital, HB Investment, Kolon Investment, Wooshin Venture Capital

## Investors

- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series A
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series A, Series B
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series A, Series B
- Wooshin Venture Capital (https://capitalatlas.ai/funds/wooshin-venture-capital) — Series A, Series B
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series B
- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Series B
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Series B